Queen Mary University of Londons BCI boosts radionuclide imaging capabilities with MILabs VECTor technology

Queen Mary University of London’s BCI boosts radionuclide imaging capabilities with MILabs VECTor technology

Milabs B.V., manufacturer of the world’s only fully integrated SPECT/PET/Optical/CT-scanner, today announces that the core molecular imaging facility at Queen Mary University of London’s Barts Cancer Institute has boosted its radionuclide imaging capabilities with a MILabs VECTor PET/SPECT/CT omni-tomography system.

More From BioPortfolio on "Queen Mary University of London’s BCI boosts radionuclide imaging capabilities with MILabs VECTor technology"